Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Infect Genet Evol. 2014 Dec 23;30:147–158. doi: 10.1016/j.meegid.2014.12.021

Table 4.

Representation 3’UTR polymorphisms of HLA-G in HIV-1 positive mothers, N (%)

Polymorphism NT
(n=144)
IP-TR
(n=29)
IU-TR
(n=19)
IU2-TR
(n=43)
IP-TR vs. NT IU-TR vs. NT IU2-TR vs. NT
OR (95%
CI)
P OR (95%
CI)
P OR (95%
CI)
P
+2961
(Indel)
D 166
(57.64)
36
(62.07)
19
(50.00)
43
(50.00)
1.20 (0.67-
2.14)
0.562 0.73 (0.37-
1.45)
0.388 0.73 (0.45-
1.19)
0.218
I 122
(42.36)
22
(37.93)
19
(50.00)
43
(50.00)
1 1 1
DD 53
(36.81)
11
(37.93)
6
(31.58)
12
(27.91)
1.61 (0.47-
5.48)
0.564 0.58 (0.17-
1.97)
0.527 0.58 (0.23-
1.45)
0.344
ID 60
(41.67)
14
(48.28)
7
(36.84)
19
(44.19)
1.81 (0.55-
5.96)
0.414 0.52 (0.16-
1.69)
0.348 0.81 (0.35-
1.90)
0.668
II 3
(21.53)
4
(13.79)
6
(31.58)
12
(27.91)
1 1 1

+3003.T/C C 31
(10.76)
9
(15.52)
1 (2.63) 4 (4.65) 1.52 (0.68-
3.40)
0.366 0.22 (0.03-
1.69)
0.149 0.40 (0.14-
1.18)
0.095
T 257
(89.24)
49
(84.48)
37
(97.37)
82
(95.35)
1 1 1
CC 4 (2.78) 1 (3.45) 0 (0.00) 0 (0.00) 1.39 (0.15-
13.1)
1.000 - 1.000 - 0.573
TC 23
(15.97)
7
(24.14)
1 (5.26) 4 (9.30) 1.69 (0.36-
4.45)
0.418 0.28 (0.03-
2.22)
0.311 0.52 (0.17-
1.60)
0.329
TT 117
(81.25)
21
(72.41)
18
(94.74)
39
(90.70)
1 1 1

+3010.C/G G 100
(34.72)
22
(37.93)
15
(39.47)
26
(30.23)
1.14 (0.64-
2.06)
0.653 1.23 (0.61-
2.45)
0.590 0.81 (0.48-
1.37)
0.516
C 188
(65.28)
36
(62.07)
23
(60.53)
60
(69.77)
1 1 1
GG 23
(15.97)
4
(13.79)
5
(26.32)
5 (11.63) 1.06 (0.31-
3.66)
1.000 1.61 (0.49-
5.32)
0.518 0.66 (0.22-
1.95)
0.609
CG 54
(37.50)
14
(48.28
5
(26.32)
16
(37.21)
1.58 (0.66-
3.76)
0.379 0.69 (0.22-
2.18)
0.582 0.90 (0.43-
1.89)
0.853
CC 67
(46.53)
11
(37.93)
9
(47.37)
22
(51.16)
1 1 1

+3027.C/A A 1 (0.35 0 (0.00) 0 (0.00) 0 (0.00) - 1.000 - 1.000 - 1.000
C 287
(99.65)
58
(100.00)
38
(100.00)
86
(100.00)
1 1 1
AA 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) - 1.000 - 1.000 - 1.000
CA 1 (0.69) 0 (0.00) 0 (0.00) 0 (0.00) - 1.000 - 1.000 - 1.000
CC 143
(99.31)
29
(100.00)
19
(100.00)
43
(100.00)
1 1 1

+3032.G/C C 4 (1.39) 1 (1.72) 1 (2.63) 2 (2.33) 1.00 (0.11-
8.66)
1.000 1.52 (0.17-
13. 5)
1.000 1.34 (0.26-
7.07)
1.000
G 284
(98.61)
57
(98.28)
37
(97.37)
84
(97.67)
1 1 1
CC 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) - 1.000 - 1.000 - 1.000
GC 4 (2.78 1 (3.45) 1 (5.26) 2 (4.65) 1.67 (0.16-
16.6)
1.000 2.59 (0.26-
26.4)
0.396 2.28 (0.37-
14.1)
0.591
GG 140
(97.22)
28
(96.55)
18
(94.74)
41
(95.35)
1 1 1

+3035.C/T C 263
(91.32
53
(91.38)
34
(89.47)
78
(90.70
1.01 (0.37-
2.75)
1.000 0.81 (0.26-
2.46)
0.760 0.93 (0.40-
2.14)
1.000
T 25
(8.68)
5 (8.62) 4
(10.53)
8 (9.30) 1 1 1
CC 121
(84.03)
24
(82.76)
15
(78.95
35
(81.40)
- 1.000 - 1.000 - 1.000
CT 21
(14.58)
5
(17.24)
4
(21.05)
8
(18.60)
- 1.000 - 1.000 - 1.000
TT 2
(1.39)
0
(0.00)
0
(0.00)
0
(0.00)
1 1 1

+3142.G/C C 100
(34.72)
22
(37.93)
15
(39.47)
26
(30.23)
1.14 (0.64-
2.06)
0.653 1.23 (0.61-
2.45)
0.590 0.81 (0.48-
1.37)
0.516
G 188
(65.28)
36
(62.07)
23
(60.53)
60
(69.77)
1 1 1
CC 23
(15.97)
4
(13.79)
5
(26.32)
5
(11.63)
1.06 (0.31-
3.65)
1.000 1.61 (0.49-
5.33)
0.518 0.66 (0.22-
1.95)
0.609
GC 54
(37.50)
14
(48.28)
5
(26.32)
16
(37.21)
1.58 (0.66-
3.76)
0.379 0.68 (0.21-
2.18)
0.582 0.90 (0.43-
1.89)
0.853
GG 67
(46.53)
11
(37.93)
9
(47.37)
22
(51.16)
1 1 1

+3187.A/G G 31
(10.76)
6
(10.34)
10
(26.32)
14
(16.28)
0.96 (0.37-
2.41)
1.000 2.96 (1.31-
6.67)
0.011 1.61 (0.81-
3.19)
0.187
A 257
(89.24)
52
(89.66)
28
(73.68)
72
(83.72)
1 1 1
GG 2 (1.39) 0 (0.00) 3
(15.79)
3 (6.98) - 1.000 14.4 (2.18-
94.7)
0.011 5.39 (0.86-
33.7)
0.080
AG 27
(18.75)
6
(20.69)
4
(21.05)
8
(18.60)
1.11 (0.41-
2.99)
1.000 1.42 (0.42-
4.74)
0.740 1.06 (0.44-
2.57)
1.000
AA 115
(79.86)
23
(79.31)
12
(63.16)
32
(74.42)
1 1 1

+3196.C/G G 97
(33.68)
17
(29.31)
15
(39.47)
35
(40.70)
0.82 (0.44-
1.51)
0.545 1.28 (0.64-
2.57)
0.586 1.35 (0.82-
2.21)
0.249
C 191
(66.32)
41
(70.69)
23
(60.53)
51
(59.30)
1 1 1
GG 18
(12.50)
2 (6.90) 4
(21.05)
7
(16.28)
0.52 (0.11-
2.48)
0.514 1.81 (0.48-
6.68)
0.464 1.68 (0.60-
4.76)
0.399
CG 61
(42.36)
13
(44.83)
7
(36.84)
21
(48.84)
0.98 (0.43-
2.27)
1.000 0.93 (0.32-
2.73)
1.000 1.49 (0.71-
3.16)
0.347
CC 65 (45.14) 14 (48.28) 8 (42.11) 15 (34.88) 1 1 1

NT: HIV-1 nontransmitting mother; IP-TR: intrapartum HIV-1 transmitting mother; IU-TR: in utero HIV-1 transmitting mother; IU2-TR: enriched group of presumed in utero transmitting mothers. Highlighted and bold P values indicate significant differences (P<0.05) and bold P values indicate trends (P<0.090).